Affiliation:
1. Division of Endocrinology, Sinai Hospital of Baltimore, and The Johns Hopkins University School of Medicine, Baltimore, Maryland 21215
Abstract
Abstract
Endogenous subclinical hyperthyroidism, defined by normal circulating levels of free T4 and T3 and low levels of TSH, is a common clinical entity and is typically caused by the same conditions that account for the majority of cases of overt hyperthyroidism: Graves’ disease, toxic multinodular goiter, and solitary autonomously functioning thyroid nodules. Subclinical hyperthyroidism has been associated with an increased risk of atrial fibrillation and mortality, decreased bone mineral density in postmenopausal women, and mild hyperthyroid symptoms. Treatment of subclinical hyperthyroidism remains controversial, given the lack of prospective randomized controlled trials showing clinical benefit with restoration of the euthyroid state. Nevertheless, it seems reasonable to treat older individuals whose serum TSH levels are less than 0.1 mU/liter and certain high-risk patients, even when the serum TSH is between 0.1 and the lower limit of the normal range.
Subject
Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Schilddrüse;Gynäkologische Endokrinologie und Kinderwunschtherapie;2023
2. Subclinical hyperthyroidism in children;Journal of Pediatric Endocrinology and Metabolism;2022-12-06
3. Thyroid disorders in elderly: A comprehensive review;Disease-a-Month;2021-11
4. Study of the relationship of thyroid status and frailty in older Egyptian men;The Egyptian Journal of Internal Medicine;2019-12
5. Acute psychosis in patients with subclinical hyperthyroidism;Psychiatry and Clinical Neurosciences;2019-04-29